Question: As of August 2016, what was the market capitalisation of the company that developed the drug Losmapimod?
Sentence (from "GlaxoSmithKline"): The company has a primary listing on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Relevant evidence: No